Thyroid hormone status within the physiological range affects bone mass and density in healthy men at the age of peak bone mass

European Journal of Endocrinology

Volumn 164, Issue 6, 2011, Pages 1027-1034

  Roef, Greet ^a   Lapauw, Bruno ^a   Goemaere, Stefan ^a   Zmierczak, Hans ^a   Fiers, Tom ^a   Kaufman, Jean Marc ^a   Taes, Youri ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROGLOBULIN; THYROID HORMONE; THYROTROPIN; THYROXINE; BIOLOGICAL MARKER;

ADULT; AGE; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; HIP; HUMAN; MALE; NORMAL HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; RADIUS; SPINE; TIBIA; TRABECULAR BONE; BODY COMPOSITION; BONE TURNOVER; FREE LIOTHYRONINE INDEX; HUMAN EXPERIMENT; IMMUNOASSAY; LIFESTYLE; PHYSIOLOGICAL PROCESS; THYROGLOBULIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADULT; AGING; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY COMPOSITION; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CROSS-SECTIONAL STUDIES; GONADAL STEROID HORMONES; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; SEX HORMONE-BINDING GLOBULIN; SMOKING; THYROID HORMONES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79957783533     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-1113     Document Type: Article

References (38)

1. Valimaki MJ, Karkkainen M, Lamberg-Allardt C, Laitinen K, Alhava E, Heikkinen J, Impivaara O, Makela P, Palmgren J & Seppanen R. Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. Cardiovascular Risk in Young Finns Study Group. BMJ 1994 309 230-235. (Pubitemid 24252658)
2. Taes YE, Lapauw B, Vanbillemont G, Bogaert V, De Bacquer D, Zmierczak H, Goemaere S & Kaufman JM. Fat mass is negatively associated with cortical bone size in young healthy male siblings. Journal of Clinical Endocrinology and Metabolism 2009 94 2325-2331. (doi:10.1210/jc.2008-2501)
3. Lapauw BM, Taes Y, Bogaert V, Vanbillemont G, Goemaere S, Zmierczak HG, De Bacquer D & Kaufman JM. Serum estradiol is associated with volumetric BMD and modulates the impact of physical activity on bone size at the age of peak bone mass: a study in healthy male siblings. Journal of Bone and Mineral Research 2009 24 1075-1085. (doi:10.1359/jbmr.081260)
4. Lapauw B, Taes Y, Goemaere S, Toye K, Zmierczak HG & Kaufman JM. Anthropometric and skeletal phenotype in men with idiopathic osteoporosis and their sons is consistent with deficient estrogen action during maturation. Journal of Clinical Endocrinology and Metabolism 2009 94 4300-4308. (doi:10.1210/jc.2009-0568)
5. Murphy E & Williams GR. The thyroid and the skeleton. Clinical Endocrinology 2004 61 285-298. (doi:10.1111/j.1365-2265.2004.02053.x)
6. Williams GR. Actions of thyroid hormones in bone. Endokrynologia Polska 2009 60 380-388.
7. Eriksen EF. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocrine Reviews 1986 7 379-408. (doi:10.1210/edrv-7-4- 379)
8. Mosekilde L, Eriksen EF & Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinology and Metabolism Clinics of North America 1990 19 35-63. (Pubitemid 20142107)
9. Vestergaard P & Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk - a meta-analysis. Thyroid 2003 13 585-593. (doi:10.1089/ 105072503322238854)
10. Lakatos P. Thyroid hormones: beneficial or deleterious for bone? Calcified Tissue International 2003 73 205-209. (doi:10.1007/s00223-002-0027-8)
11. Karga H, Papapetrou PD, Korakovouni A, Papandroulaki F, Polymeris A & Pampouras G. Bone mineral density in hyperthyroidism. Clinical Endocrinology 2004 61 466-472. (doi:10.1111/j.1365-2265.2004.02110.x)
12. Vestergaard P & Mosekilde L. Fractures in patients with hyperthyroidism and hypothyroidism: a nationwide follow-up study in 16 249 patients. Thyroid 2002 12 411-419. (doi:10.1089/105072502760043503)
13. Murphy E, Gluer CC, Reid DM, Felsenberg D, Roux C, Eastell R & Williams GR. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2010 95 3173-3181. (doi:10.1210/jc.2009-2630)
14. 4 levels and the TSHR-Asp727Glu polymorphism on bone: the Rotterdam Study. Clinical Endocrinology 2008 68 175-181. (doi:10.1111/j.1365-2265.2007.03016.x)
15. Taes Y, Lapauw B, Vanbillemont G, Bogaert V, De Bacquer D, Goemaere S, Zmierczak H & Kaufman JM. Early smoking is associated with peak bone mass and prevalent fractures in young healthy men. Journal of Bone and Mineral Research 2009 25 379-387. (doi:10.1359/jbmr.090809)
16. Lohman T, Roche A, Martorell R. Anthropometric Standardization Reference Manual, 1 edn. Champaign, IL, USA: Human Kinetics Books, 1988.
17. Thienpont LM, Van Uytfanghe K, Beastall G, Faix JD, Ieiri T, Miller WG, Nelson JC, Ronin C, Ross HA, Thijssen JH & Toussaint B. Report of the IFCC Working Group for Standardization of Thyroid Function Tests; part 2: free thyroxine and free triiodothyronine. Clinical Chemistry 2010 56 912-920. (doi:10.1373/clinchem.2009.140194)
18. Von Recklinghausen FD. Die Fibröse oder deformierende Ostitis, die Osteomalazie und die osteoplastische Carzinose in ihren gegenseitigen Beziehungen. Berlin, 1891.
19. Rosen CJ & Adler RA. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. Journal of Clinical Endocrinology and Metabolism 1992 75 1531-1534. (doi:10.1210/jc.75.6.1531)
20. Grant DJ, McMurdo ME, Mole PA & Paterson CR. Is previous hyperthyroidism still a risk factor for osteoporosis in postmenopausal women? Clinical Endocrinology 1995 43 339-345. (doi:10.1111/j.1365-2265.1995.tb02041.x)
21. Bauer DC, Nevitt MC, Ettinger B & Stone K. Low thyrotropin levels are not associated with bone loss in older women: a prospective study. Journal of Clinical Endocrinology and Metabolism 1997 82 2931-2936. (doi:10.1210/jc.82.9. 2931)
22. Bauer DC, Ettinger B, Nevitt MC & Stone KL. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Annals of Internal Medicine 2001 134 561-568. (Pubitemid 32245317)
23. Kim DJ, Khang YH, Koh JM, Shong YK & Kim GS. Low normal TSH levels are associated with low bone mineral density in healthy postmenopausal women. Clinical Endocrinology 2006 64 86-90. (doi:10.1111/j.1365-2265.2005.02422.x)
24. Ross DS. Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid 1994 4 319-326. (doi:10.1089/thy.1994.4.319)
25. Heemstra KA, Hoftijzer H, van der Deure WM, Peeters RP, Hamdy NA, Pereira A, Corssmit EP, Romijn JA, Visser TJ & Smit JW. The type 2 deiodinase Thr92Ala polymorphism is associated with increased bone turn-over and decreased femoral neck bone mineral density. Journal of Bone and Mineral Research 2010 25 1385-1391. (doi:10.1002/jbmr.27)
26. Williams AJ, Robson H, Kester MH, van Leeuwen JP, Shalet SM, Visser TJ & Williams GR. Iodothyronine deiodinase enzyme activities in bone. Bone 2008 43 126-134. (doi:10.1016/j.bone.2008.03.019)
27. Tahboub R & Arafah BM. Sex steroids and the thyroid. Best Practice and Research. Clinical Endocrinology and Metabolism 2009 23 769-780. (doi:10.1016/j.beem.2009.06.005)
28. Rudorff KH. Thyroxine-binding globulin (TBG). Clinical studies on the regulation of TBG concentration in serum and the value of TBG for the evaluation of thyroid function. Fortschritte der Medizin 1979 97 2038-2045. (Pubitemid 10159170)
29. Inada M & Sterling K. Thyroxine transport in thyrotoxicosis and hypothyroidism. Journal of Clinical Investigations 1967 46 1442-1450. (doi:10.1172/JCI105636)
30. Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Journal of Clinical Investigation 2005 26 97-122.
31. Szulc P, Kaufman JM & Delmas PD. Biochemical assessment of bone turnover and bone fragility in men. Osteoporosis International 2007 18 1451-1461. (doi:10.1007/s00198-007-0407-z)
32. Szulc P & Seeman E. Thinking inside and outside the envelopes of bone: dedicated to PDD. Osteoporosis International 2009 20 1281-1288. (doi:10.1007/s00198-009-0994-y)
33. Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF & Zaidi M. TSH is a negative regulator of skeletal remodeling. Cell 2003 115 151-162. (doi:10.1016/S0092-8674(03)00771-2)
34. Grimnes G, Emaus N, Joakimsen RM, Figenschau Y & Jorde R. The relationship between serum TSH and bone mineral density in men and postmenopausal women: the Tromso study. Thyroid 2008 18 1147-1155. (doi:10.1089/thy.2008.0158)
35. Morris MS. The association between serum thyroid-stimulating hormone in its reference range and bone status in postmenopausal American women. Bone 2007 40 1128-1134. (doi:10.1016/j.bone.2006.12.001)
36. Svare A, Nilsen TI, Bjoro T, Forsmo S, Schei B & Langhammer A. Hyperthyroid levels of TSH correlate with low bone mineral density: the HUNT 2 study. European Journal of Endocrinology 2009 161 779-786. (doi:10.1530/EJE-09- 0139)
37. Mazziotti G, Porcelli T, Patelli I, Vescovi PP & Giustina A. Serum TSH values and risk of vertebral fractures in euthyroid postmenopausal women with low bone mineral density. Bone 2010 46 747-751. (doi:10.1016/j.bone.2009. 10.031)
38. Bassett JH & Williams GR. Critical role of the hypothalamic- pituitary-thyroid axis in bone. Bone 2008 43 418-426. (doi:10.1016/j.bone.2008. 05.007)